Shanghai Chest Hospital
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- -
- Established
- 1957-01-01
- Employees
- -
- Market Cap
- -
Association of Psychological Distress in Patients With Lung Cancer
- First Posted Date
- 2024-01-23
- Last Posted Date
- 2024-01-23
- Lead Sponsor
- Shanghai Chest Hospital
- Target Recruit Count
- 500
- Registration Number
- NCT06218901
- Locations
- 🇨🇳
Shanghai Chest Hospital, Shanghai, Shanghai, China
Blinded Randomized Controlled Trial of Artificial Intelligence Guided Detection of Intracardiac Thrombus
Not Applicable
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-01-16
- Last Posted Date
- 2024-01-16
- Lead Sponsor
- Shanghai Chest Hospital
- Target Recruit Count
- 1500
- Registration Number
- NCT06206187
- Locations
- 🇨🇳
Shanghai Chest Hospital, Shanghai, 上海市, China
Neoadjuvant Adebrelimab Plus Chemotherapy for Resectable ESCC: a Single Arm, Prospective Phase 2 Clinical Trial
Phase 2
Not yet recruiting
- Conditions
- First Posted Date
- 2023-12-20
- Last Posted Date
- 2023-12-20
- Lead Sponsor
- Shanghai Chest Hospital
- Target Recruit Count
- 36
- Registration Number
- NCT06178211
- Locations
- 🇨🇳
Shanghai Chest Hospital, Shanghai, China
Immunotherapy in Combination With Chemoradiotherapy in Unresectable Locally Advanced Esophageal Cancer
Phase 1
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-12-18
- Last Posted Date
- 2023-12-18
- Lead Sponsor
- Shanghai Chest Hospital
- Target Recruit Count
- 50
- Registration Number
- NCT06173986
- Locations
- 🇨🇳
Shanghai Chest Hospital, Shanghai, China
A Multi-center RCT to Evaluate Subsegmental BTVA Treatment for Severe Emphysema
Not Applicable
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-11-30
- Last Posted Date
- 2023-11-30
- Lead Sponsor
- Shanghai Chest Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT06152107
Toripalimab Combined with Cryoablation for First-line Oligo-progression in Driver-negative Advanced NSCLC
Phase 2
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-11-13
- Last Posted Date
- 2024-10-14
- Lead Sponsor
- Shanghai Chest Hospital
- Target Recruit Count
- 54
- Registration Number
- NCT06127303
- Locations
- 🇨🇳
Shanghai General Hospital, Shanghai Jiaotong University, Shanghai, China
🇨🇳Zhongshan Hospital, Fudan University, Shanghai, China
🇨🇳Shanghai Chest Hospital, Shanghai, Shanghai, China
RAE Versus MIE in Patients With Esophageal Cancer After Neoadjuvant Therapy
Not Applicable
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-08-25
- Last Posted Date
- 2023-08-25
- Lead Sponsor
- Shanghai Chest Hospital
- Target Recruit Count
- 300
- Registration Number
- NCT06012214
- Locations
- 🇨🇳
Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China
Radiotherapy Combined With Immunochemotherapy in Metastatic Esophageal Squamous Cell Carcinoma
Phase 2
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-08-07
- Last Posted Date
- 2023-08-07
- Lead Sponsor
- Shanghai Chest Hospital
- Target Recruit Count
- 160
- Registration Number
- NCT05978193
- Locations
- 🇨🇳
Shanghai Ruijin Hospital, Shanghai, China
🇨🇳Shanghai Chest Hospital, Shanghai, China
Molecular Analysis and Treatment Options of SCLC
- First Posted Date
- 2023-07-14
- Last Posted Date
- 2024-11-28
- Lead Sponsor
- Shanghai Chest Hospital
- Target Recruit Count
- 500
- Registration Number
- NCT05945745
- Locations
- 🇨🇳
Shanghai Chest Hospital, Shanghai, China
A Randomized Controlled Study of Ablation Pursuing Atrial Fibrillation Termination as a Procedural Endpoint in Patients With Persistent Atrial Fibrillation
Not Applicable
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-06-27
- Last Posted Date
- 2023-06-27
- Lead Sponsor
- Shanghai Chest Hospital
- Target Recruit Count
- 544
- Registration Number
- NCT05921734
- Locations
- 🇨🇳
Mu Qin, Shanghai, China
🇨🇳Shanghai Chest Hospital, Shanghai, China
© Copyright 2024. All Rights Reserved by MedPath